FDA Drug Application (202353) for PRAMIPEXOLE DIHYDROCHLORIDE by SANDOZ INC

Back to FDA Applications sponsored by SANDOZ INC

Application Number202353
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage0.375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NamePRAMIPEXOLE DIHYDROCHLORIDE
Active IngredientPRAMIPEXOLE DIHYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PRAMIPEXOLE DIHYDROCHLORIDE3


Back to FDA Applications sponsored by SANDOZ INC